Who is sponsoring NCT03934008?

NCT03934008 is sponsored by Cedarville University.

What drugs are being tested in NCT03934008?

Interventions in NCT03934008: MOtivational interviewing Tool to Improve Vaccine AdherencE (MOTIVE).

What condition does NCT03934008 study?

NCT03934008 studies Vaccine Hesitancy.

Is NCT03934008 still recruiting?

NCT03934008 is currently completed. Last updated 9 September 2020.

Last reviewed 2020-09-09 · How we verify

NCT03934008: MOTIVE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Motivational Interviewing and Vaccine Hesitancy in Children

Completed Last updated 9 September 2020

What this trial tests

trial testing MOtivational interviewing Tool to Improve Vaccine AdherencE (MOTIVE) in Vaccine Hesitancy in 4,191 participants. Completed in 9 March 2020.

Timeline

1 April 2019

Primary endpoint
9 March 2020

9 March 2020

Quick facts

Lead sponsor	Cedarville University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	4,191
Start date	1 April 2019
Primary completion	9 March 2020
Estimated completion	9 March 2020
Sites	1 location across United States

Drugs / interventions tested

MOtivational interviewing Tool to Improve Vaccine AdherencE (MOTIVE)

Conditions studied

Vaccine Hesitancy — all drugs for Vaccine Hesitancy →

Sponsor

Cedarville University

Who can join

Adults 0 to 6, any sex, with Vaccine Hesitancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will assess the effectiveness of a motivational interviewing-based tool in addressing vaccine hesitancy expressed by parents or caregivers of children.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Motivational interviewing and vaccine acceptance in children: The MOTIVE study.
Cole JW, M H Chen A, McGuire K, Berman S, et al · · 2022 · cited 24× · PMID 35153096 · DOI 10.1016/j.vaccine.2022.01.058

Verify or expand the search:

Other recruiting trials for Vaccine Hesitancy

Currently open trials in the same condition.

NCT06988969 — Predicting Vaccine Hesitancy Using Machine Learning · active not recruiting
NCT06513494 — Active Health Education to Increase HPV Vaccine Coverage in Youth: A Stepped-wedge, Cluster, and Randomized Trial · NA · recruiting
NCT06237374 — Supporting CHWs as Vaccine Educators: Impact of a Digital Training and Chatbot Intervention on Vaccination in Kenya · NA · active not recruiting
NCT05910879 — RADx-UP Phase 3D (Oregon Saludable: Juntos Podemos) · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03934008 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cedarville University
Last refreshed: 9 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03934008.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing